| Literature DB >> 16807448 |
Abstract
In the last 20-30 years the approach to metastatic breast cancer by chemotherapy has been largely studied. Anthracyclines, taxanes and, more recently, capecitabine and gemcitabine represent the breakthrough of treatment. In the next future the combination of chemotherapy and target therapy will be considered more frequently.Entities:
Mesh：
Year: 2006 PMID： 16807448 DOI： 10.1093/annonc/mdj974
Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976